GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Price (Quote)

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $3.02 $6.17 Friday, 27th May 2022 CATB stock ended at $3.36. This is 6.16% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 6.65% from a day low at $3.16 to a day high of $3.37.
90 days $3.02 $7.25
52 weeks $1.20 $10.26

Historical Catabasis Pharmaceuticals prices

Date Open High Low Close Volume
2021-09-17 $8.54 $8.54 $8.54 $8.54 0
2021-09-16 $8.54 $8.54 $8.54 $8.54 0
2021-09-15 $8.54 $8.54 $8.54 $8.54 0
2021-09-14 $8.54 $8.54 $8.54 $8.54 0
2021-09-13 $8.54 $8.54 $8.54 $8.54 0
2021-09-10 $8.54 $8.54 $8.54 $8.54 0
2021-09-09 $8.54 $8.54 $8.54 $8.54 0
2021-09-08 $9.21 $9.21 $8.46 $8.54 98 872
2021-09-07 $9.57 $9.68 $8.95 $9.18 94 109
2021-09-03 $10.07 $10.18 $9.44 $9.53 81 959
2021-09-02 $9.60 $10.26 $9.60 $10.06 110 014
2021-09-01 $10.00 $10.19 $9.37 $9.41 83 488
2021-08-31 $9.38 $10.09 $9.38 $9.97 171 538
2021-08-30 $9.45 $9.48 $9.31 $9.43 50 143
2021-08-27 $9.07 $9.63 $9.06 $9.36 155 662
2021-08-26 $9.20 $9.50 $9.05 $9.07 127 096
2021-08-25 $9.37 $9.60 $9.01 $9.26 318 044
2021-08-24 $8.74 $8.77 $8.28 $8.72 154 327
2021-08-23 $7.28 $8.97 $7.21 $8.80 585 817
2021-08-20 $6.45 $8.57 $6.31 $7.58 5 341 744
2021-08-19 $1.31 $1.32 $1.20 $1.22 747 794
2021-08-18 $1.30 $1.34 $1.27 $1.30 318 411
2021-08-17 $1.33 $1.33 $1.26 $1.32 307 718
2021-08-16 $1.33 $1.36 $1.29 $1.32 403 320
2021-08-13 $1.35 $1.39 $1.32 $1.34 265 440
Click to get the best stock tips daily for free!

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... CATB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT